Fei Jing

4.3k total citations
124 papers, 3.0k citations indexed

About

Fei Jing is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Fei Jing has authored 124 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Epidemiology and 18 papers in Surgery. Recurrent topics in Fei Jing's work include Liver Disease Diagnosis and Treatment (7 papers), Geotechnical Engineering and Soil Stabilization (6 papers) and Diet, Metabolism, and Disease (6 papers). Fei Jing is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Geotechnical Engineering and Soil Stabilization (6 papers) and Diet, Metabolism, and Disease (6 papers). Fei Jing collaborates with scholars based in China, Japan and United States. Fei Jing's co-authors include Masaki Mogi, Masatsugu Horiuchi, Li‐Juan Min, Kana Tsukuda, Jun Iwanami, Jiajun Zhao, Kousei Ohshima, Shaohong Zang, Jie Gao and Gongying Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Fei Jing

119 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Jing China 31 761 496 381 378 352 124 3.0k
Mei Hong China 36 1.0k 1.3× 890 1.8× 242 0.6× 154 0.4× 489 1.4× 112 4.0k
Zheng Shen China 38 1.1k 1.4× 645 1.3× 149 0.4× 439 1.2× 532 1.5× 192 4.8k
Linhua Zhang China 35 2.2k 2.9× 365 0.7× 254 0.7× 178 0.5× 182 0.5× 165 5.1k
Bo Fu China 34 1.1k 1.5× 207 0.4× 81 0.2× 270 0.7× 162 0.5× 125 3.3k
Kang Sun China 37 724 1.0× 217 0.4× 538 1.4× 698 1.8× 42 0.1× 174 3.9k
Ruixia Li China 30 589 0.8× 483 1.0× 102 0.3× 86 0.2× 137 0.4× 113 2.8k
Li Cui China 36 1.5k 2.0× 409 0.8× 105 0.3× 182 0.5× 697 2.0× 176 4.3k
Liqun Jiang China 41 1.4k 1.8× 242 0.5× 51 0.1× 181 0.5× 400 1.1× 157 5.0k
Fan He China 46 1.2k 1.6× 428 0.9× 56 0.1× 176 0.5× 786 2.2× 166 6.0k
Zhe Cai China 26 509 0.7× 232 0.5× 130 0.3× 122 0.3× 289 0.8× 100 2.5k

Countries citing papers authored by Fei Jing

Since Specialization
Citations

This map shows the geographic impact of Fei Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Jing more than expected).

Fields of papers citing papers by Fei Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Jing. The network helps show where Fei Jing may publish in the future.

Co-authorship network of co-authors of Fei Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Jing. A scholar is included among the top collaborators of Fei Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Jing. Fei Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hongxia, et al.. (2025). The characterization and validation of regulated cell death-related genes in chronic rhinosinusitis with nasal polyps. International Immunopharmacology. 154. 114509–114509.
2.
Zheng, Runsheng, Jiaojiao Zhang, Zhigang Zhang, et al.. (2025). Development and application of antibody-drug conjugates in gynecological cancers. Science China Life Sciences. 69(2). 331–352. 1 indexed citations
4.
Li, Long, Wenlei Wang, Pinghu Zhang, et al.. (2024). Unlocking the potential of phenolated kraft lignin as a versatile feed additive. International Journal of Biological Macromolecules. 271(Pt 2). 132234–132234. 5 indexed citations
5.
Jing, Fei, Jing Wang, Pei Liu, et al.. (2024). Evaluating PAX1/JAM3 methylation for triage in HPV 16/18-infected women. Clinical Epigenetics. 16(1). 190–190. 3 indexed citations
6.
Jiang, Xiuyun, Qing Chen, Xiaoyu Chen, et al.. (2024). Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome. BMC Cardiovascular Disorders. 24(1). 191–191. 2 indexed citations
7.
Wu, Yingyi, et al.. (2023). Isorhynchophylline attenuates proliferation and migration of synovial fibroblasts via the FOXC1/β-catenin axis. Autoimmunity. 56(1). 2289868–2289868. 4 indexed citations
8.
Chen, Huanhuan, et al.. (2023). ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer. Journal for ImmunoTherapy of Cancer. 11(2). e005527–e005527. 13 indexed citations
9.
Huang, Xin, Wei Sun, Bin Nie, et al.. (2023). Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway. Open Medicine. 18(1). 20230850–20230850. 2 indexed citations
10.
Li, Jiji, Shuai Mao, Yingying Ye, et al.. (2021). Micro-polyethylene particles reduce the toxicity of nano zinc oxide in marine microalgae by adsorption. Environmental Pollution. 290. 118042–118042. 26 indexed citations
11.
Huang, Yang, et al.. (2020). Bufotalin ameliorates experimental Sjögren’s syndrome development by inhibiting Th17 generation. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(10). 1977–1985. 8 indexed citations
12.
Jing, Fei, et al.. (2020). Involvement of GDNF/PI3K/AKT pathway in promoting facial nerve regeneration using electroacupuncture in a rabbit model of facial nerve crush injury. 24(7). 1094–1100. 1 indexed citations
13.
Shen, Jiayu, et al.. (2019). Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis. Journal of Ovarian Research. 12(1). 110–110. 30 indexed citations
14.
Wang, Dongxu, Chengsheng Zhang, Xiuyun Jiang, et al.. (2018). Clinical Diagnosis of X-Linked Spondyloepiphyseal Dysplasia Tarda and a Novel Missense Mutation in the Sedlin Gene (SEDL). International Journal of Endocrinology. 2018. 1–7. 1 indexed citations
15.
Zhang, Jianmei, Wenbin Chen, Fang Li, et al.. (2018). Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease. Wiener klinische Wochenschrift. 130(11-12). 390–397. 12 indexed citations
16.
Luo, Ping, Fei Jing, Jianwei Zhou, & Weijiang Zhang. (2015). microRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3 cells. Oncology Letters. 9(5). 2225–2229. 18 indexed citations
17.
Li, Qinghe, Nan Wang, Zhuo Du, et al.. (2012). Gastrocnemius transcriptome analysis reveals domestication induced gene expression changes between wild and domestic chickens. Genomics. 100(5). 314–319. 18 indexed citations
18.
Zhou, Jianwei, et al.. (2012). Expression of cofilin 1 is positively correlated with the differentiation of human epithelial ovarian cancer. Oncology Letters. 4(6). 1187–1190. 32 indexed citations
19.
Jing, Fei. (2006). Test on strength of unsaturated remolded expansive soils. Chinese Journal of Geotechnical Engineering. 1 indexed citations
20.
Jing, Fei. (2003). Settlement prediction of embankments with stage construction on soft ground. Chinese Jounal of Geotechnical Engineering. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026